REGENERON PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 أغسطس 2024 08:47:18 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 أغسطس 2024 08:50:04 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 أغسطس 2024 10:58:01 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 أغسطس 2024 08:45:08 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

14 أغسطس 2024 09:27:20 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 أغسطس 2024 08:50:04 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

09 أغسطس 2024 08:48:01 بحسب NetDania Notify

Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast

07 أغسطس 2024 15:05:01 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 أغسطس 2024 08:46:30 بحسب NetDania Notify

Regeneron Reports Second Quarter 2024 Financial and Operating Results

01 أغسطس 2024 05:30:00 بحسب Nasdaq GlobeNewswire

Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation

31 يوليو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

12 يوليو 2024 08:45:06 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

11 يوليو 2024 09:10:53 بحسب NetDania Notify

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

03 يوليو 2024 00:00:00 بحسب Nasdaq GlobeNewswire

Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

28 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

27 يونيو 2024 15:05:00 بحسب Nasdaq GlobeNewswire

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

26 يونيو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 يونيو 2024 08:45:03 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

24 يونيو 2024 08:56:19 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 يونيو 2024 09:29:52 بحسب NetDania Notify